(-)-alpha-phellandrene increases expression ISO RGD:1343160 6480464 alpha phellandrene results in increased expression of H1F2 mRNA CTD PMID:25075043 (-)-demecolcine increases expression ISO RGD:1343160 6480464 Demecolcine results in increased expression of H1-2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1343160 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of H1-2 mRNA CTD PMID:22079256 1,1-dichloroethene decreases expression ISO RGD:1624044 6480464 vinylidene chloride results in decreased expression of H1F2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1624044 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of H1F2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1624044 6480464 1, 2-Dimethylhydrazine results in decreased expression of H1F2 mRNA CTD PMID:22206623 14-Deoxy-11,12-didehydroandrographolide increases expression ISO RGD:1343160 6480464 14-deoxy-11, 12-didehydroandrographolide results in increased expression of H1-2 mRNA CTD PMID:22101062 17alpha-ethynylestradiol affects expression ISO RGD:1624044 6480464 Ethinyl Estradiol affects the expression of H1F2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1624044 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of H1F2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1624044 6480464 Ethinyl Estradiol results in decreased expression of H1F2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1343160 6480464 [Estradiol co-treated with Norethindrone Acetate] results in increased expression of H1-2 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of H1-2 mRNA CTD PMID:17404688 , PMID:22217510 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of H1F2 protein CTD PMID:32145629 17beta-estradiol increases expression ISO RGD:1343160 6480464 Estradiol results in increased expression of H1-2 mRNA CTD PMID:20106945 , PMID:21632981 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1343160 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1624044 6480464 Tetrachlorodibenzodioxin affects the expression of H1F2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1343160 6480464 Tetrachlorodibenzodioxin results in increased expression of H1-2 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of H1F2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1624044 6480464 Tetrachlorodibenzodioxin results in decreased expression of H1F2 mRNA CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1624044 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of H1F2 mRNA CTD PMID:17942748 2-hydroxypropanoic acid affects expression ISO RGD:1343160 6480464 Lactic Acid affects the expression of H1-2 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1343160 6480464 beta-methylcholine affects the expression of H1-2 mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1343160 6480464 tetrabromobisphenol A results in increased expression of H1-2 protein CTD PMID:31675489 4,4'-sulfonyldiphenol increases expression ISO RGD:1624044 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of H1F2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1624044 6480464 Fenretinide results in decreased expression of H1F2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1343160 6480464 [Decitabine co-treated with Vorinostat] affects the expression of H1-2 mRNA CTD PMID:17330099 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of H1F2 mRNA CTD PMID:25825206 aconitine increases expression EXP 6480464 Aconitine results in increased expression of H1F2 protein CTD PMID:33236894 adefovir pivoxil increases expression ISO RGD:1343160 6480464 adefovir dipivoxil results in increased expression of H1-2 mRNA CTD PMID:25596134 aflatoxin B1 increases expression ISO RGD:1343160 6480464 Aflatoxin B1 results in increased expression of H1-2 mRNA CTD PMID:27153756 aflatoxin B1 affects expression ISO RGD:1343160 6480464 Aflatoxin B1 affects the expression of H1-2 protein CTD PMID:20106945 aldehydo-D-glucose increases expression ISO RGD:1624044 6480464 Glucose results in increased expression of H1F2 mRNA CTD PMID:17178593 all-trans-retinoic acid multiple interactions ISO RGD:1343160 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of H1-2 mRNA CTD PMID:15894607 all-trans-retinoic acid increases expression ISO RGD:1343160 6480464 Tretinoin results in increased expression of H1-2 mRNA CTD PMID:16249480 all-trans-retinoic acid decreases expression ISO RGD:1343160 6480464 Tretinoin results in decreased expression of H1-2 mRNA CTD PMID:33167477 alpha-phellandrene increases expression ISO RGD:1343160 6480464 alpha phellandrene results in increased expression of H1F2 mRNA CTD PMID:25075043 aminoglutethimide increases expression ISO RGD:1343160 6480464 Aminoglutethimide results in increased expression of H1-2 protein CTD PMID:26102013 antimycin A increases expression ISO RGD:1343160 6480464 Antimycin A results in increased expression of H1-2 mRNA CTD PMID:33512557 aristolochic acid A increases expression ISO RGD:1343160 6480464 aristolochic acid I results in increased expression of H1-2 mRNA CTD PMID:33212167 arsenous acid multiple interactions ISO RGD:1343160 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of H1-2 mRNA CTD PMID:15894607 atrazine increases expression ISO RGD:1343160 6480464 Atrazine results in increased expression of H1-2 mRNA CTD PMID:22378314 benzene decreases expression ISO RGD:1624044 6480464 Benzene results in decreased expression of H1F2 mRNA CTD PMID:15120971 , PMID:15122651 benzo[a]pyrene increases expression ISO RGD:1624044 6480464 Benzo(a)pyrene results in increased expression of H1F2 mRNA CTD PMID:15034205 more ... benzo[a]pyrene increases expression ISO RGD:1343160 6480464 Benzo(a)pyrene results in increased expression of H1-2 mRNA CTD PMID:20064835 more ... benzo[a]pyrene multiple interactions ISO RGD:1624044 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H1F2 mRNA CTD PMID:27858113 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1343160 6480464 7 more ... CTD PMID:17944540 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1343160 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1624044 6480464 benzo(b)fluoranthene results in increased expression of H1F2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:1624044 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H1F2 mRNA CTD PMID:27858113 Benzo[k]fluoranthene increases expression ISO RGD:1624044 6480464 benzo(k)fluoranthene results in increased expression of H1F2 mRNA CTD PMID:26377693 beta-naphthoflavone increases expression ISO RGD:1343160 6480464 beta-Naphthoflavone results in increased expression of H1-2 mRNA CTD PMID:19737606 bisphenol A increases expression ISO RGD:1624044 6480464 bisphenol A results in increased expression of H1F2 mRNA CTD PMID:30951980 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of H1F2 protein CTD PMID:32145629 bisphenol A decreases expression ISO RGD:1343160 6480464 bisphenol A results in decreased expression of H1-2 mRNA CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of H1F2 mRNA CTD PMID:30816183 bisphenol F increases expression ISO RGD:1624044 6480464 bisphenol F results in increased expression of H1F2 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1343160 6480464 bisphenol F results in increased expression of H1-2 protein CTD PMID:34186270 cadmium atom multiple interactions ISO RGD:1343160 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of H1-2 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO RGD:1343160 6480464 Cadmium Chloride results in increased expression of H1-2 mRNA CTD PMID:25596134 cadmium dichloride multiple interactions ISO RGD:1343160 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of H1-2 mRNA CTD PMID:35301059 calcium silicate decreases expression ISO RGD:1624044 6480464 calcium silicate results in decreased expression of H1F2 mRNA CTD PMID:29279043 cannabidiol increases expression ISO RGD:1624044 6480464 Cannabidiol results in increased expression of H1F2 mRNA CTD PMID:21542829 carbon nanotube decreases expression ISO RGD:1624044 6480464 Nanotubes more ... CTD PMID:25554681 chloroacetaldehyde increases expression ISO RGD:1343160 6480464 chloroacetaldehyde results in increased expression of H1-2 mRNA CTD PMID:25596134 chloropicrin decreases expression ISO RGD:1343160 6480464 chloropicrin results in decreased expression of H1-2 mRNA CTD PMID:26352163 chrysene multiple interactions ISO RGD:1624044 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H1F2 mRNA CTD PMID:27858113 cidofovir anhydrous increases expression ISO RGD:1343160 6480464 Cidofovir results in increased expression of H1-2 mRNA CTD PMID:25596134 cisplatin affects expression ISO RGD:1624044 6480464 Cisplatin affects the expression of H1F2 mRNA CTD PMID:21151649 cisplatin increases expression ISO RGD:1343160 6480464 Cisplatin results in increased expression of H1-2 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:1343160 6480464 Cisplatin results in decreased expression of H1-2 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1343160 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of H1-2 mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:1624044 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of H1F2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of H1F2 mRNA] CTD PMID:17585979 clozapine increases expression ISO RGD:1343160 6480464 Clozapine results in increased expression of H1-2 protein CTD PMID:34122009 cobalt dichloride decreases expression ISO RGD:1343160 6480464 cobaltous chloride results in decreased expression of H1-2 mRNA CTD PMID:19320972 , PMID:19376846 copper atom increases expression ISO RGD:1624044 6480464 Copper results in increased expression of H1F2 mRNA CTD PMID:17205981 copper atom multiple interactions ISO RGD:1343160 6480464 [NSC 689534 binds to Copper] which results in increased expression of H1-2 mRNA CTD PMID:20971185 copper(0) increases expression ISO RGD:1624044 6480464 Copper results in increased expression of H1F2 mRNA CTD PMID:17205981 copper(0) multiple interactions ISO RGD:1343160 6480464 [NSC 689534 binds to Copper] which results in increased expression of H1-2 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:1343160 6480464 Copper Sulfate results in increased expression of H1-2 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1343160 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H1-2 mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:1343160 6480464 Coumestrol results in decreased expression of H1-2 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1343160 6480464 Asbestos, Crocidolite results in increased expression of H1-2 mRNA CTD PMID:18687144 cyclosporin A decreases expression ISO RGD:1343160 6480464 Cyclosporine results in decreased expression of H1-2 mRNA CTD PMID:27989131 cyclosporin A affects expression ISO RGD:1343160 6480464 Cyclosporine affects the expression of H1-2 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1343160 6480464 Cyclosporine results in increased expression of H1-2 mRNA CTD PMID:25562108 , PMID:25596134 cypermethrin decreases expression ISO RGD:1624044 6480464 cypermethrin results in decreased expression of H1F2 mRNA CTD PMID:29020013 cytarabine decreases expression ISO RGD:1343160 6480464 Cytarabine results in decreased expression of H1-2 mRNA CTD PMID:21198554 D-glucose increases expression ISO RGD:1624044 6480464 Glucose results in increased expression of H1F2 mRNA CTD PMID:17178593 decabromodiphenyl ether increases expression ISO RGD:1343160 6480464 decabromobiphenyl ether results in increased expression of H1-2 protein CTD PMID:31675489 deguelin increases expression ISO RGD:1343160 6480464 deguelin results in increased expression of H1-2 mRNA CTD PMID:33512557 deoxynivalenol increases expression ISO RGD:1343160 6480464 deoxynivalenol results in increased expression of H1-2 mRNA CTD PMID:31863870 diallyl trisulfide decreases expression ISO RGD:1343160 6480464 diallyl trisulfide results in decreased expression of H1-2 mRNA CTD PMID:34995734 diarsenic trioxide multiple interactions ISO RGD:1343160 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of H1-2 mRNA CTD PMID:15894607 dibenz[a,h]anthracene increases expression ISO RGD:1624044 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:1624044 6480464 Dibutyl Phthalate results in decreased expression of H1F2 mRNA CTD PMID:17361019 dicrotophos decreases expression ISO RGD:1343160 6480464 dicrotophos results in decreased expression of H1-2 mRNA CTD PMID:28302478 dioxygen affects expression ISO RGD:1343160 6480464 Oxygen deficiency affects the expression of H1-2 mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:1343160 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H1-2 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1343160 6480464 Doxorubicin results in increased expression of H1-2 mRNA CTD PMID:29803840 doxorubicin affects response to substance ISO RGD:1343160 6480464 H1-2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 endosulfan increases expression ISO RGD:1343160 6480464 Endosulfan results in increased expression of H1-2 protein CTD PMID:26615145 Enterolactone multiple interactions ISO RGD:1343160 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H1-2 mRNA CTD PMID:19167446 ethanol affects expression ISO RGD:1624044 6480464 Ethanol affects the expression of H1F2 mRNA CTD PMID:30319688 ethanol decreases expression ISO RGD:1343160 6480464 Ethanol results in decreased expression of H1-2 mRNA CTD PMID:23378141 ethyl methanesulfonate decreases expression ISO RGD:1343160 6480464 Ethyl Methanesulfonate results in decreased expression of H1-2 mRNA CTD PMID:23649840 fenofibrate decreases expression ISO RGD:1343160 6480464 Fenofibrate results in decreased expression of H1-2 mRNA CTD PMID:25596134 fenpyroximate increases expression ISO RGD:1343160 6480464 fenpyroximate results in increased expression of H1-2 mRNA CTD PMID:33512557 fluoranthene decreases expression ISO RGD:1624044 6480464 fluoranthene results in decreased expression of H1F2 mRNA CTD PMID:28329830 folic acid decreases expression ISO RGD:1624044 6480464 Folic Acid results in decreased expression of H1F2 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1624044 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of H1F2 mRNA CTD PMID:22206623 fumonisin B1 increases expression ISO RGD:1624044 6480464 fumonisin B1 results in increased expression of H1F2 mRNA CTD PMID:16221962 furan increases expression ISO RGD:1624044 6480464 furan results in increased expression of H1F2 mRNA CTD PMID:24183702 genistein increases expression ISO RGD:1624044 6480464 Genistein results in increased expression of H1F2 mRNA CTD PMID:32186404 genistein multiple interactions ISO RGD:1343160 6480464 ESR2 promotes the reaction [Genistein results in increased expression of H1-2 protein] CTD PMID:20884965 genistein increases expression ISO RGD:1343160 6480464 Genistein results in increased expression of H1-2 protein CTD PMID:20884965 glucose increases expression ISO RGD:1624044 6480464 Glucose results in increased expression of H1F2 mRNA CTD PMID:17178593 hydrazine increases expression ISO RGD:1624044 6480464 hydrazine results in increased expression of H1F2 mRNA CTD PMID:15282401 hydrogen peroxide decreases expression ISO RGD:1343160 6480464 Hydrogen Peroxide results in decreased expression of H1-2 mRNA CTD PMID:18951874 ibuprofen decreases expression ISO RGD:1343160 6480464 Ibuprofen results in decreased expression of H1-2 mRNA CTD PMID:25596134 indirubin decreases phosphorylation ISO RGD:1624044 6480464 indirubin results in decreased phosphorylation of H1F2 protein CTD PMID:18344322 indirubin multiple interactions ISO RGD:1624044 6480464 [tanshinone co-treated with tetraarsenic tetrasulfide] promotes the reaction [indirubin results in decreased phosphorylation of H1F2 protein] more ... CTD PMID:18344322 isoflavones affects expression ISO RGD:1343160 6480464 Isoflavones affects the expression of H1-2 mRNA CTD PMID:16365062 isoprenaline increases expression ISO RGD:1624044 6480464 Isoproterenol results in increased expression of H1F2 mRNA CTD PMID:20003209 isotretinoin decreases expression ISO RGD:1343160 6480464 Isotretinoin results in decreased expression of H1-2 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1343160 6480464 Ivermectin results in decreased expression of H1-2 protein CTD PMID:32959892 lipopolysaccharide increases expression ISO RGD:1624044 6480464 Lipopolysaccharides results in increased expression of H1F2 mRNA CTD PMID:27339419 lithium chloride decreases expression ISO RGD:1343160 6480464 Lithium Chloride results in decreased expression of H1-2 mRNA CTD PMID:15711924 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of H1F2 mRNA CTD PMID:28801915 metformin decreases expression ISO RGD:1343160 6480464 Metformin results in decreased expression of H1-2 mRNA CTD PMID:25596134 methylisothiazolinone decreases expression ISO RGD:1343160 6480464 2-methyl-4-isothiazolin-3-one results in decreased expression of H1-2 mRNA CTD PMID:31629900 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1343160 6480464 N more ... CTD PMID:19013360 N-methyl-4-phenylpyridinium increases expression ISO RGD:1624044 6480464 1-Methyl-4-phenylpyridinium results in increased expression of H1F2 protein CTD PMID:26558463 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of H1F2 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions ISO RGD:1624044 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of H1F2 mRNA CTD PMID:24535843 N-Nitrosopyrrolidine decreases expression ISO RGD:1343160 6480464 N-Nitrosopyrrolidine results in decreased expression of H1-2 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1624044 6480464 Nickel results in increased expression of H1F2 mRNA CTD PMID:18922574 ozone increases phosphorylation EXP 6480464 Ozone results in increased phosphorylation of H1F2 protein CTD PMID:33146391 paracetamol multiple interactions ISO RGD:1624044 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of H1F2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of H1F2 mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:1343160 6480464 Acetaminophen results in increased expression of H1-2 mRNA CTD PMID:21420995 , PMID:25596134 perfluorooctanoic acid multiple interactions ISO RGD:1343160 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of H1-2 mRNA CTD PMID:33325755 perfluorooctanoic acid increases expression ISO RGD:1343160 6480464 perfluorooctanoic acid results in increased expression of H1-2 mRNA CTD PMID:36326898 phenobarbital multiple interactions ISO RGD:1624044 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of H1F2 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of H1F2 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:1624044 6480464 Phenobarbital results in increased expression of H1F2 mRNA CTD PMID:19482888 phytoestrogen multiple interactions ISO RGD:1343160 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of H1-2 mRNA CTD PMID:33325755 pirinixic acid increases expression ISO RGD:1624044 6480464 pirinixic acid results in increased expression of H1F2 mRNA CTD PMID:18445702 more ... pirinixic acid multiple interactions ISO RGD:1624044 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of H1F2 mRNA] CTD PMID:20059764 potassium chromate multiple interactions ISO RGD:1343160 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of H1-2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1343160 6480464 potassium chromate(VI) results in decreased expression of H1-2 mRNA CTD PMID:22079256 progesterone increases expression ISO RGD:1624044 6480464 Progesterone results in increased expression of H1F2 mRNA CTD PMID:22238285 progesterone multiple interactions ISO RGD:1343160 6480464 [Progesterone co-treated with Estradiol] results in increased expression of H1-2 mRNA CTD PMID:17404688 propiconazole increases expression ISO RGD:1624044 6480464 propiconazole results in increased expression of H1F2 mRNA CTD PMID:21278054 pyrimidifen increases expression ISO RGD:1343160 6480464 pyrimidifen results in increased expression of H1-2 mRNA CTD PMID:33512557 quercetin increases expression ISO RGD:1343160 6480464 Quercetin results in increased expression of H1-2 mRNA CTD PMID:21632981 rac-lactic acid affects expression ISO RGD:1343160 6480464 Lactic Acid affects the expression of H1-2 mRNA CTD PMID:30851411 rotenone increases expression ISO RGD:1343160 6480464 Rotenone results in increased expression of H1-2 mRNA CTD PMID:29955902 , PMID:33512557 SB 431542 multiple interactions ISO RGD:1343160 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H1-2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1624044 6480464 Silicon Dioxide results in increased expression of H1F2 mRNA CTD PMID:19073995 silicon dioxide increases expression ISO RGD:1343160 6480464 Silicon Dioxide analog results in increased expression of H1-2 mRNA, Silicon Dioxide results in increased expression of H1-2 mRNA CTD PMID:23806026 , PMID:25351596 sodium arsenite decreases expression ISO RGD:1624044 6480464 sodium arsenite results in decreased expression of H1F2 protein CTD PMID:29044176 sotorasib multiple interactions ISO RGD:1343160 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of H1-2 mRNA CTD PMID:36139627 succimer multiple interactions ISO RGD:1624044 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of H1F2 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1343160 6480464 Sunitinib results in decreased expression of H1-2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1624044 6480464 Tamoxifen affects the expression of H1F2 mRNA CTD PMID:17555576 Tanshinone I multiple interactions ISO RGD:1624044 6480464 [tanshinone co-treated with tetraarsenic tetrasulfide] promotes the reaction [indirubin results in decreased phosphorylation of H1F2 protein], tanshinone promotes the reaction [indirubin results in decreased phosphorylation of H1F2 protein] CTD PMID:18344322 tebufenpyrad increases expression ISO RGD:1343160 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of H1-2 mRNA CTD PMID:33512557 tetrachloromethane increases expression ISO RGD:1624044 6480464 Carbon Tetrachloride results in increased expression of H1F2 mRNA CTD PMID:27339419 , PMID:31919559 tetraphene multiple interactions ISO RGD:1624044 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H1F2 mRNA CTD PMID:27858113 thapsigargin decreases expression ISO RGD:1624044 6480464 Thapsigargin results in decreased expression of H1F2 protein CTD PMID:24648495 thapsigargin increases expression ISO RGD:1343160 6480464 Thapsigargin results in increased expression of H1-2 mRNA CTD PMID:22378314 thifluzamide increases expression ISO RGD:1343160 6480464 thifluzamide results in increased expression of H1-2 mRNA CTD PMID:33512557 titanium dioxide decreases expression ISO RGD:1624044 6480464 titanium dioxide results in decreased expression of H1F2 mRNA CTD PMID:23409001 , PMID:27760801 titanium dioxide increases expression ISO RGD:1624044 6480464 titanium dioxide results in increased expression of H1F2 mRNA CTD PMID:23557971 trametinib multiple interactions ISO RGD:1343160 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of H1-2 mRNA CTD PMID:36139627 tremolite asbestos increases expression ISO RGD:1624044 6480464 tremolite results in increased expression of H1F2 mRNA CTD PMID:29279043 Tributyltin oxide decreases phosphorylation ISO RGD:1624044 6480464 bis(tri-n-butyltin)oxide results in decreased phosphorylation of H1F2 protein CTD PMID:22174045 trichostatin A multiple interactions ISO RGD:1343160 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H1-2 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO RGD:1343160 6480464 trichostatin A results in decreased expression of H1-2 mRNA CTD PMID:26272509 triptonide decreases expression ISO RGD:1624044 6480464 triptonide results in decreased expression of H1F2 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1343160 6480464 Troglitazone results in increased expression of H1-2 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO RGD:1624044 6480464 trovafloxacin results in decreased expression of H1F2 mRNA CTD PMID:35537566 valproic acid increases expression ISO RGD:1343160 6480464 Valproic Acid results in increased expression of H1-2 mRNA CTD PMID:28001369 valproic acid decreases expression ISO RGD:1343160 6480464 Valproic Acid results in decreased expression of H1-2 mRNA CTD PMID:29154799 valproic acid decreases methylation ISO RGD:1343160 6480464 Valproic Acid results in decreased methylation of H1-2 gene CTD PMID:29154799 vandetanib increases expression ISO RGD:1343160 6480464 vandetanib results in increased expression of H1-2 mRNA CTD PMID:16052530 vincaleukoblastine affects response to substance ISO RGD:1343160 6480464 H1-2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vorinostat multiple interactions ISO RGD:1343160 6480464 [Decitabine co-treated with Vorinostat] affects the expression of H1-2 mRNA CTD PMID:17330099 zoledronic acid increases expression ISO RGD:1343160 6480464 Zoledronic Acid results in increased expression of H1-2 mRNA CTD PMID:24714768 , PMID:25596134